Cryo-Cell International, Inc. (CCEL)
NYSEAMERICAN: CCEL · Real-Time Price · USD
7.37
+0.16 (2.22%)
At close: Nov 4, 2024, 4:00 PM
7.49
+0.12 (1.63%)
After-hours: Nov 4, 2024, 7:06 PM EST
Cryo-Cell International Revenue
Cryo-Cell International had revenue of $8.07M in the quarter ending August 31, 2024, with 2.50% growth. This brings the company's revenue in the last twelve months to $31.84M, up 1.95% year-over-year. In the fiscal year ending November 30, 2023, Cryo-Cell International had annual revenue of $31.34M with 3.32% growth.
Revenue (ttm)
$31.84M
Revenue Growth
+1.95%
P/S Ratio
1.89
Revenue / Employee
$361,801
Employees
88
Market Cap
59.42M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Nov 30, 2023 | 31.34M | 1.01M | 3.32% |
Nov 30, 2022 | 30.34M | 1.45M | 5.03% |
Nov 30, 2021 | 28.88M | -2.26M | -7.26% |
Nov 30, 2020 | 31.15M | -668.98K | -2.10% |
Nov 30, 2019 | 31.82M | 2.60M | 8.89% |
Nov 30, 2018 | Pro | Pro | Pro |
Nov 30, 2017 | Pro | Pro | Pro |
Nov 30, 2016 | Pro | Pro | Pro |
Nov 30, 2015 | Pro | Pro | Pro |
Nov 30, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
DIH Holding US | 67.62M |
Enzo Biochem | 31.91M |
Prenetics Global | 22.66M |
Aligos Therapeutics | 7.97M |
VolitionRx | 976.52K |
CCEL News
- 5 days ago - Cord Blood Banking Leader Cryo-Cell Declares Initiation of Regular Quarterly Cash Dividend - Business Wire
- 20 days ago - Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2024 Financial Results - Business Wire
- 4 months ago - Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2024 Financial Results - Business Wire
- 7 months ago - Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2024 Financial Results - Business Wire
- 8 months ago - Cryo-Cell Announces Plans to Explore Strategic Alternatives and Spin-off Celle Corp. to Maximize Shareholder Value - Business Wire
- 8 months ago - Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2023 - Business Wire
- 1 year ago - Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2023 Financial Results - Business Wire
- 1 year ago - Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2023 Financial Results - Business Wire